APVO - CIK 0001671584
Aptevo Therapeutics Inc. has filed 690 documents with the SEC between 2016 and 2026. The most frequent type is insider trade (221 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Major company event | 8-K | 2025-07-24 | 2025-07-24 |
| Insider trade | 4 | 2025-07-21 | 2025-07-17 |
| Insider trade | 4 | 2025-07-21 | 2025-07-17 |
| Insider trade | 4 | 2025-07-21 | 2025-07-17 |
| Insider trade | 4 | 2025-07-21 | 2025-07-17 |
| Insider trade | 4 | 2025-07-21 | 2025-07-17 |
| Insider trade | 4 | 2025-07-21 | 2025-07-17 |
| Insider trade | 4 | 2025-07-21 | 2025-07-17 |
| Insider trade | 4 | 2025-07-21 | 2025-07-17 |
| Insider trade | 4 | 2025-07-21 | 2025-07-17 |
| New insider ownership | 3 | 2025-07-09 | 2025-07-01 |
| SCHEDULE 13G | - | 2025-07-08 | - |
| Proxy statement | DEF 14A | 2025-07-03 | 2025-07-24 |
| Annual report to shareholders | ARS | 2025-07-03 | 2025-07-03 |
| Major company event | 8-K | 2025-07-01 | 2025-07-01 |
| Major company event | 8-K | 2025-06-30 | 2025-06-30 |
| SCHEDULE 13G | - | 2025-06-25 | - |
| SCHEDULE 13G | - | 2025-06-25 | - |
| SCHEDULE 13G | - | 2025-06-23 | - |
| SCHEDULE 13G/A | - | 2025-06-23 | - |
| PRE 14A | - | 2025-06-23 | 2025-07-24 |
| Major company event | 8-K | 2025-06-23 | 2025-06-23 |
| Major company event | 8-K | 2025-06-20 | 2025-06-20 |
| Prospectus supplement | 424B5 | 2025-06-20 | - |
| Major company event | 8-K | 2025-06-20 | 2025-06-18 |
| 424B4 | - | 2025-06-20 | - |
| EFFECT | - | 2025-06-18 | - |
| S-1MEF | - | 2025-06-18 | - |
| Major company event | 8-K | 2025-06-17 | 2025-06-16 |
| Company correspondence | CORRESP | 2025-06-16 | - |
| IPO registration | S-1 | 2025-06-16 | - |
| SEC correspondence | UPLOAD | 2025-06-04 | - |
| DRS | - | 2025-05-30 | - |
| 424B3 | - | 2025-05-28 | - |
| Major company event | 8-K | 2025-05-23 | 2025-05-23 |
| EFFECT | - | 2025-05-22 | - |
| Major company event | 8-K | 2025-05-22 | 2025-05-22 |
| Prospectus supplement | 424B5 | 2025-05-22 | - |
| Company correspondence | CORRESP | 2025-05-21 | - |
| SEC correspondence | UPLOAD | 2025-05-20 | - |
| Quarterly report | 10-Q | 2025-05-15 | 2025-03-31 |
| Major company event | 8-K | 2025-05-15 | 2025-05-15 |
| IPO registration | S-1 | 2025-05-13 | - |
| RW | - | 2025-05-13 | - |
| RW | - | 2025-05-13 | - |
| Securities registration | S-3 | 2025-05-02 | - |
| Major company event | 8-K | 2025-04-29 | 2025-04-29 |
| Prospectus supplement | 424B5 | 2025-04-29 | - |
| 424B4 | - | 2025-04-28 | - |
| Major company event | 8-K | 2025-04-28 | 2025-04-28 |